Numerous parameters, such as CD4 cell count, CD4/CD8 ratio, viral load, concurrent hepatitis C infection, and gender differences, have been proposed as potential factors in the serum conversion rate following HAV immunization [106]. The gene discussed is CD4; the disease is hepatitis C virus infection.